Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP51A1 | Q16850 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.40 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.40 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16748959 | 0.91 | CA1 (0.58) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL17513820 | 0.90 | ALDH1A1 (0.57) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL17513819 | 0.90 | ALDH1A1 (0.57) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL13667432 | 0.82 | CA1 (0.52) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL15845029 | 0.82 | CA1 (0.52) | CA1CA2CA9CA5ACA5B | |
| Toluene SCHEMBL27755902 | 0.81 | ALDH1A1 (0.46) | CA1CA2CA9CA5ACA5B | |
| Chlorobenzene SCHEMBL28995009 | 0.81 | ALDH1A1 (0.46) | CA1CA2CA9CA5ACA5B | |
| Hydrochloric Acid SCHEMBL28769370 | 0.80 | CA1 (0.50) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL23091565 | 0.78 | CA1 (0.54) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL13449658 | 0.78 | CA2 (0.54) | CA1CA2CA9CA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110038890-A1 | Cellular And Viral Inactivation | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2011-02-17 | — | — | US | disclosed |
| US-20110038890-A1 | Cellular And Viral Inactivation | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2011-02-17 | — | — | US | disclosed |
| WO-2009131606-A2 | VIRAL INACTIVATION USING CROSSLINKERS AND DETERGENTS | BELANGER JULIE M (US) | 2009-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110038890-A1 | Cellular And Viral Inactivation | PDIA5, HAVCR2, MAVS | CA1 2171/4885CA2 3118/4885CA9 2934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.